Earnings call transcript: Procter & Gamble tops Q1 2027 estimates as shares jump
Procter & Gamble reported Q1 2027 earnings of $2.00 per share, beating estimates of $1.89, on revenue of $23.28B, exceeding forecasts of $22.82B. Organic sales grew 4.0%, with all 10 product categories showing growth. Shares rose 5.84% in premarket trading. The company maintained its full-year guidance but raised its cost headwind outlook to $1.4B after tax.
How this was made
The 30-second read
Why it matters
The beat sparked a 5.8% pre‑market rally, indicating strong investor demand for the stock despite rising input costs.
Market read
First‑report earnings for a large‑cap consumer staple; immediate price impact and sector‑wide implications.
What to watch
The unchanged FY guidance despite cost pressure may signal future margin compression.
Background
Procter & Gamble released its fiscal Q1 2027 earnings, beating both earnings and revenue estimates.
Ticker impact
PG reported Q1 FY2027 core EPS $2.00 vs $1.89 estimate and revenue $23.28B vs $22.82B, sending the stock up 5.84% pre‑market.
upward bias as market prices in the earnings beat and robust sales growth
The beat is material for a large‑cap consumer staple; the pre‑market rally confirms immediate buying pressure, while raised cost outlook suggests caution on the upside.
Market effects
Consumer staples may see broader optimism as a bellwether beats, but cost‑inflation concerns could affect peers.
U.S. market gains from the beat; European and Asian markets may react to cost‑headwind commentary.
Limited to consumer‑goods sector, but the move influences risk‑on sentiment in equities.
Counterpoint
Higher raw‑material and freight costs could erode margins, making the rally potentially short‑lived.
Key entities
- executiveAndre Schulten
Chief Financial Officer who commented on growth and cost pressures.



